BridgeBio price target raised to $107 from $102 at Truist Financial
Upside potential from PT raise.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
Upside potential from PT raise.
What happened, with direct paths to the underlying reporting
BBIO received an analyst target update from Truist Financial.
Target: $107
Posted price: $83.89
Analyst firm: Truist Financial
Analyst: Danielle Brill
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.